64 related articles for article (PubMed ID: 8317271)
1. Excitatory amino acids: physiological and pharmacological probes for neuroscience research.
Shinozaki H; Ishida M
Acta Neurobiol Exp (Wars); 1993; 53(1):43-51. PubMed ID: 8317271
[TBL] [Abstract][Full Text] [Related]
2. Potentiation by DL-alpha-aminopimelate of the inhibitory action of a novel mGluR agonist (L-F2CCG-I) on monosynaptic excitation in the rat spinal cord.
Saitoh T; Ishida M; Shinozaki H
Br J Pharmacol; 1998 Feb; 123(4):771-9. PubMed ID: 9517398
[TBL] [Abstract][Full Text] [Related]
3. A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord.
Ishida M; Saitoh T; Shimamoto K; Ohfune Y; Shinozaki H
Br J Pharmacol; 1993 Aug; 109(4):1169-77. PubMed ID: 8401927
[TBL] [Abstract][Full Text] [Related]
4. Potent NMDA-like actions and potentiation of glutamate responses by conformational variants of a glutamate analogue in the rat spinal cord.
Shinozaki H; Ishida M; Shimamoto K; Ohfune Y
Br J Pharmacol; 1989 Dec; 98(4):1213-24. PubMed ID: 2692753
[TBL] [Abstract][Full Text] [Related]
5. A metabotropic L-glutamate receptor agonist: pharmacological difference between rat central neurones and crayfish neuromuscular junctions.
Shinozaki H; Ishida M
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Sep; 103(1):13-7. PubMed ID: 1360366
[TBL] [Abstract][Full Text] [Related]
6. Changes in preference for receptor subtypes of configurational variants of a glutamate analog: conversion from the NMDA-type to the non-NMDA type.
Ishida M; Ohfune Y; Shimada Y; Shimamoto K; Shinozaki H
Brain Res; 1991 May; 550(1):152-6. PubMed ID: 1653635
[TBL] [Abstract][Full Text] [Related]
7. A conformationally restricted analogue of L-glutamate, the (2S,3R,4S) isomer of L-alpha-(carboxycyclopropyl)glycine, activates the NMDA-type receptor more markedly than NMDA in the isolated rat spinal cord.
Shinozaki H; Ishida M; Shimamoto K; Ohfune Y
Brain Res; 1989 Feb; 480(1-2):355-9. PubMed ID: 2565750
[TBL] [Abstract][Full Text] [Related]
8. L-CCG-I activates group III metabotropic glutamate receptors in the hippocampal CA3 region.
Kirschstein T; von der Brelie C; Steinhäuser M; Vinçon A; Beck H; Dietrich D
Neuropharmacology; 2004 Aug; 47(2):157-62. PubMed ID: 15223294
[TBL] [Abstract][Full Text] [Related]
9. A significant increase in intracellular Ca2+ concentration induced by (2S,3R,4S)-2-(carboxycyclopropyl)glycine, a new potent NMDA agonist, in cultured rat hippocampal neurons.
Kudo Y; Akita K; Ishida M; Shinozaki H
Brain Res; 1991 Dec; 567(2):342-5. PubMed ID: 1840131
[TBL] [Abstract][Full Text] [Related]
10. Novel kainate derivatives: potent depolarizing actions on spinal motoneurones and dorsal root fibres in newborn rats.
Ishida M; Shinozaki H
Br J Pharmacol; 1991 Dec; 104(4):873-8. PubMed ID: 1687368
[TBL] [Abstract][Full Text] [Related]
11. 2-(Carboxycyclopropyl)glycines: binding, neurotoxicity and induction of intracellular free Ca2+ increase.
Kawai M; Horikawa Y; Ishihara T; Shimamoto K; Ohfune Y
Eur J Pharmacol; 1992 Feb; 211(2):195-202. PubMed ID: 1319341
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacology of the glutamate receptor].
Shinozaki H
Nihon Yakurigaku Zasshi; 2000 Sep; 116(3):125-31. PubMed ID: 11031741
[TBL] [Abstract][Full Text] [Related]
13. Evaluation and comparison of ion permeation and agonist selectivities for N-methyl-d-aspartate receptor channels with different subunit compositions in bilayer lipid membranes based on integrated single-channel currents.
Hirano A; Wakabayashi M; Sugawara M; Uchino S; Nakajima-Iijima S
Anal Biochem; 2000 Aug; 283(2):258-65. PubMed ID: 10906247
[TBL] [Abstract][Full Text] [Related]
14. (2S,3S,4R)-2-(carboxycyclopropyl)glycine, a potent and competitive inhibitor of both glial and neuronal uptake of glutamate.
Nakamura Y; Kataoka K; Ishida M; Shinozaki H
Neuropharmacology; 1993 Sep; 32(9):833-7. PubMed ID: 7901789
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by folded isomers of L-2-(carboxycyclopropyl)glycine of glutamate uptake via the human glutamate transporter hGluT-1.
Yamashita H; Kawakami H; Zhang YX; Hagiwara T; Tanaka K; Nakamura S
Eur J Pharmacol; 1995 Apr; 289(2):387-90. PubMed ID: 7621914
[TBL] [Abstract][Full Text] [Related]
16. A potent metabotropic glutamate receptor agonist: electrophysiological actions of a conformationally restricted glutamate analogue in the rat spinal cord and Xenopus oocytes.
Ishida M; Akagi H; Shimamoto K; Ohfune Y; Shinozaki H
Brain Res; 1990 Dec; 537(1-2):311-4. PubMed ID: 1964837
[TBL] [Abstract][Full Text] [Related]
17. Group II metabotropic glutamate receptor-mediated regulation of dopamine release from slices of rat nucleus accumbens.
Chaki S; Yoshikawa R; Okuyama S
Neurosci Lett; 2006 Aug; 404(1-2):182-6. PubMed ID: 16781059
[TBL] [Abstract][Full Text] [Related]
18. Neuron damage induced by some potent kainoids and neuroprotective action of new agonists for metabotropic glutamate receptors.
Shinozaki H
Eur Neurol; 1994; 34 Suppl 3():2-9. PubMed ID: 7821331
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacology of excitatory amino acid receptors].
Shinozaki H
Yakubutsu Seishin Kodo; 1992 Apr; 12(2):55-65. PubMed ID: 1359719
[TBL] [Abstract][Full Text] [Related]
20. Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes.
Cartmell J; Adam G; Chaboz S; Henningsen R; Kemp JA; Klingelschmidt A; Metzler V; Monsma F; Schaffhauser H; Wichmann J; Mutel V
Br J Pharmacol; 1998 Feb; 123(3):497-504. PubMed ID: 9504391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
